Involvement of brain-derived neurotrophic factor in cannabinoid receptor-dependent protection against excitotoxicity - PubMed

Comparative Study

Involvement of brain-derived neurotrophic factor in cannabinoid receptor-dependent protection against excitotoxicity

Leonid G Khaspekov et al. Eur J Neurosci. 2004 Apr.

Abstract

Cannabinoid type 1 (CB1) receptors play a central role in the protection against excitotoxicity induced by treatment of mice with kainic acid (KA). As inactivation of CB1 receptor function in mice blocks KA-induced increase of brain-derived neurotrophic factor (BDNF) mRNA levels in hippocampus, the notion was put forward that BDNF might be a mediator, at least in part, of CB1 receptor-dependent neuroprotection [Marsicano et al. (2003) Science, 302, 84-88]. To assess this signalling cascade in more detail, organotypic hippocampal slice cultures were used, as this in vitro system conserves morphological and functional properties of the hippocampus. Here, we show that both genetic ablation of CB1 receptors and pharmacological blockade with the specific CB1 receptor antagonist SR141716A increased the susceptibility of the in vitro cultures to KA-induced excitotoxicity, leading to extensive neuronal death. Next, we found that the application of SR141716A to hippocampal cultures from wild-type mice abolished the KA-induced increase in BDNF protein levels. Therefore, we tried to rescue these organotypic cultures from neuronal death by exogenously applied BDNF. Indeed, BDNF was sufficient to prevent KA-induced neuronal death after blockade of CB1 receptor signalling. In conclusion, our results strongly suggest that BDNF is a key mediator in CB1 receptor-dependent protection against excitotoxicity, and further underline the physiological importance of the endogenous cannabinoid system in neuroprotection.

Similar articles

• CB1 cannabinoid receptors and on-demand defense against excitotoxicity.

  Marsicano G, Goodenough S, Monory K, Hermann H, Eder M, Cannich A, Azad SC, Cascio MG, Gutiérrez SO, van der Stelt M, López-Rodriguez ML, Casanova E, Schütz G, Zieglgänsberger W, Di Marzo V, Behl C, Lutz B. Marsicano G, et al. Science. 2003 Oct 3;302(5642):84-8. doi: 10.1126/science.1088208. Science. 2003. PMID: 14526074

• Topiramate protects against glutamate excitotoxicity via activating BDNF/TrkB-dependent ERK pathway in rodent hippocampal neurons.

  Mao XY, Cao YG, Ji Z, Zhou HH, Liu ZQ, Sun HL. Mao XY, et al. Prog Neuropsychopharmacol Biol Psychiatry. 2015 Jul 3;60:11-7. doi: 10.1016/j.pnpbp.2015.01.015. Epub 2015 Feb 7. Prog Neuropsychopharmacol Biol Psychiatry. 2015. PMID: 25661849

• The excitoprotective effect of N-methyl-D-aspartate receptors is mediated by a brain-derived neurotrophic factor autocrine loop in cultured hippocampal neurons.

  Jiang X, Tian F, Mearow K, Okagaki P, Lipsky RH, Marini AM. Jiang X, et al. J Neurochem. 2005 Aug;94(3):713-22. doi: 10.1111/j.1471-4159.2005.03200.x. Epub 2005 Jul 5. J Neurochem. 2005. PMID: 16000165

• Prosaposin, a neurotrophic factor, protects neurons against kainic acid-induced neurotoxicity.

  Nabeka H. Nabeka H. Anat Sci Int. 2021 Jun;96(3):359-369. doi: 10.1007/s12565-021-00605-y. Epub 2021 Feb 3. Anat Sci Int. 2021. PMID: 33534127 Review.

• Neuroprotective effects of melatonin.

  Lipartiti M, Franceschini D, Zanoni R, Gusella M, Giusti P, Cagnoli CM, Kharlamov A, Manev H. Lipartiti M, et al. Adv Exp Med Biol. 1996;398:315-21. doi: 10.1007/978-1-4613-0381-7_49. Adv Exp Med Biol. 1996. PMID: 8906283 Review.

Cited by

• Role for Endogenous BDNF in Endocannabinoid-Mediated Long-Term Depression at Neocortical Inhibitory Synapses.

  Zhao L, Yeh ML, Levine ES. Zhao L, et al. eNeuro. 2015 Feb 28;2(2):ENEURO.0029-14.2015. doi: 10.1523/ENEURO.0029-14.2015. eNeuro. 2015. PMID: 25938134 Free PMC article.

• The endocannabinoid system as a target for the treatment of neurodegenerative disease.

  Scotter EL, Abood ME, Glass M. Scotter EL, et al. Br J Pharmacol. 2010 Jun;160(3):480-98. doi: 10.1111/j.1476-5381.2010.00735.x. Br J Pharmacol. 2010. PMID: 20590559 Free PMC article. Review.

• Cannabinoid receptors and their role in neuroprotection.

  van der Stelt M, Di Marzo V. van der Stelt M, et al. Neuromolecular Med. 2005;7(1-2):37-50. doi: 10.1385/NMM:7:1-2:037. Neuromolecular Med. 2005. PMID: 16052037 Review.

• BDNF-induced endocannabinoid release modulates neocortical glutamatergic neurotransmission.

  Yeh ML, Selvam R, Levine ES. Yeh ML, et al. Synapse. 2017 May;71(5):10.1002/syn.21962. doi: 10.1002/syn.21962. Epub 2017 Feb 11. Synapse. 2017. PMID: 28164368 Free PMC article.

• Interactions between the Kynurenine and the Endocannabinoid System with Special Emphasis on Migraine.

  Nagy-Grócz G, Zádor F, Dvorácskó S, Bohár Z, Benyhe S, Tömböly C, Párdutz Á, Vécsei L. Nagy-Grócz G, et al. Int J Mol Sci. 2017 Jul 30;18(8):1617. doi: 10.3390/ijms18081617. Int J Mol Sci. 2017. PMID: 28758944 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.
  • Wiley

• Molecular Biology Databases

  • Mouse Genome Informatics (MGI)

• Research Materials

  • NCI CPTC Antibody Characterization Program